Vulvar Lichen Sclerosus Vls clinical trials

Explore recruiting vulvar lichen sclerosus vls clinical trials.

Also recruiting in Europe

Vulvar Lichen Sclerosus Vls trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A parallel group (2-arm), randomised, double-blind, 12-week trial to explore the efficacy and safety of MC2-25 cream and MC2-25 vehicle in women diagnosed with vulvar lichen sclerosus (VLS)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Vulvar Lichen Sclerosus Vls trials by city

Vulvar Lichen Sclerosus Vls in Toronto Vulvar Lichen Sclerosus Vls in Vancouver Vulvar Lichen Sclerosus Vls in Montreal Vulvar Lichen Sclerosus Vls in Calgary Vulvar Lichen Sclerosus Vls in Edmonton Vulvar Lichen Sclerosus Vls in Ottawa Vulvar Lichen Sclerosus Vls in Winnipeg Vulvar Lichen Sclerosus Vls in Quebec City Vulvar Lichen Sclerosus Vls in Hamilton Vulvar Lichen Sclerosus Vls in Kitchener Vulvar Lichen Sclerosus Vls in London Vulvar Lichen Sclerosus Vls in Halifax Vulvar Lichen Sclerosus Vls in New York Vulvar Lichen Sclerosus Vls in Los Angeles Vulvar Lichen Sclerosus Vls in Chicago Vulvar Lichen Sclerosus Vls in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease